J B Chemicals & Pharmaceuticals allots 85,390 equity shares under ESOS
11 - Jun - 2025 12:00 | 6 days ago
J B Chemicals & Pharmaceuticals has allotted 85,390 equity shares under ESOS. Consequently, the issued, subscribed and paid up capital has increased from 15,59,73,534 equity shares of Re. 1 each to 15,60,58,924 equity shares of Re. 1 each.
J B Chemicals & Pharmaceuticals allots 1.12 lakh equity shares under ESOS
05 - Jun - 2025 12:00 | 12 days ago
J B Chemicals & Pharmaceuticals has allotted 112,990 fully paid up equity shares of Re. 1/- each of the Company, to certain employees on exercise of stock options granted to them pursuant to JBCPL Employee Stock Option Scheme, 2021. An amount of Rs. 5,16,30,125 has been realised on exercise of 112,990 stock options.
Consequently, the issued, subscribed and paid up capital has increased from 15,58,60,544 equity shares of Re. 1 each to 15,59,73,534 equity shares of Re. 1 each.
Board of J B Chemicals & Pharmaceuticals recommends final dividend
15 - May - 2025 12:00 | 33 days ago
J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 7 per equity Share (i.e. 700%) , subject to the approval of the shareholders.
J B Chemicals & Pharmaceuticals allots 1.12 lakh equity shares under ESOS
05 - Jun - 2025 12:00 | 12 days ago
J B Chemicals & Pharmaceuticals has allotted 112,990 fully paid up equity shares of Re. 1/- each of the Company, to certain employees on exercise of stock options granted to them pursuant to JBCPL Employee Stock Option Scheme, 2021. An amount of Rs. 5,16,30,125 has been realised on exercise of 112,990 stock options.
Consequently, the issued, subscribed and paid up capital has increased from 15,58,60,544 equity shares of Re. 1 each to 15,59,73,534 equity shares of Re. 1 each.
Board of J B Chemicals & Pharmaceuticals recommends final dividend
15 - May - 2025 12:00 | 33 days ago
J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 7 per equity Share (i.e. 700%) , subject to the approval of the shareholders.
J B Chemicals & Pharmaceuticals consolidated net profit rises 15.48% in the March 2025 quarter
15 - May - 2025 12:00 | 33 days ago
Net profit of J B Chemicals & Pharmaceuticals rose 15.48% to Rs 145.69 crore in the quarter ended March 2025 as against Rs 126.16 crore during the previous quarter ended March 2024. Sales rose 10.18% to Rs 949.48 crore in the quarter ended March 2025 as against Rs 861.73 crore during the previous quarter ended March 2024.
For the full year,net profit rose 19.35% to Rs 659.58 crore in the year ended March 2025 as against Rs 552.63 crore during the previous year ended March 2024. Sales rose 12.45% to Rs 3917.99 crore in the year ended March 2025 as against Rs 3484.18 crore during the previous year ended March 2024.
J B Chemicals & Pharmaceuticals allots 85,390 equity shares under ESOS
11 - Jun - 2025 12:00 | 6 days ago
J B Chemicals & Pharmaceuticals has allotted 85,390 equity shares under ESOS. Consequently, the issued, subscribed and paid up capital has increased from 15,59,73,534 equity shares of Re. 1 each to 15,60,58,924 equity shares of Re. 1 each.
J B Chemicals & Pharmaceuticals allots 1.12 lakh equity shares under ESOS
05 - Jun - 2025 12:00 | 12 days ago
J B Chemicals & Pharmaceuticals has allotted 112,990 fully paid up equity shares of Re. 1/- each of the Company, to certain employees on exercise of stock options granted to them pursuant to JBCPL Employee Stock Option Scheme, 2021. An amount of Rs. 5,16,30,125 has been realised on exercise of 112,990 stock options.
Consequently, the issued, subscribed and paid up capital has increased from 15,58,60,544 equity shares of Re. 1 each to 15,59,73,534 equity shares of Re. 1 each.
Board of J B Chemicals & Pharmaceuticals recommends final dividend
15 - May - 2025 12:00 | 33 days ago
J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 7 per equity Share (i.e. 700%) , subject to the approval of the shareholders.
J B Chemicals & Pharmaceuticals consolidated net profit rises 15.48% in the March 2025 quarter
15 - May - 2025 12:00 | 33 days ago
Net profit of J B Chemicals & Pharmaceuticals rose 15.48% to Rs 145.69 crore in the quarter ended March 2025 as against Rs 126.16 crore during the previous quarter ended March 2024. Sales rose 10.18% to Rs 949.48 crore in the quarter ended March 2025 as against Rs 861.73 crore during the previous quarter ended March 2024.
For the full year,net profit rose 19.35% to Rs 659.58 crore in the year ended March 2025 as against Rs 552.63 crore during the previous year ended March 2024. Sales rose 12.45% to Rs 3917.99 crore in the year ended March 2025 as against Rs 3484.18 crore during the previous year ended March 2024.
J B Chemicals & Pharmaceuticals allots 85,390 equity shares under ESOS
11 - Jun - 2025 12:00 | 6 days ago
J B Chemicals & Pharmaceuticals has allotted 85,390 equity shares under ESOS. Consequently, the issued, subscribed and paid up capital has increased from 15,59,73,534 equity shares of Re. 1 each to 15,60,58,924 equity shares of Re. 1 each.
J B Chemicals & Pharmaceuticals allots 1.12 lakh equity shares under ESOS
05 - Jun - 2025 12:00 | 12 days ago
J B Chemicals & Pharmaceuticals has allotted 112,990 fully paid up equity shares of Re. 1/- each of the Company, to certain employees on exercise of stock options granted to them pursuant to JBCPL Employee Stock Option Scheme, 2021. An amount of Rs. 5,16,30,125 has been realised on exercise of 112,990 stock options.
Consequently, the issued, subscribed and paid up capital has increased from 15,58,60,544 equity shares of Re. 1 each to 15,59,73,534 equity shares of Re. 1 each.
Board of J B Chemicals & Pharmaceuticals recommends final dividend
15 - May - 2025 12:00 | 33 days ago
J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 7 per equity Share (i.e. 700%) , subject to the approval of the shareholders.
J B Chemicals & Pharmaceuticals allots 1.12 lakh equity shares under ESOS
05 - Jun - 2025 12:00 | 12 days ago
J B Chemicals & Pharmaceuticals has allotted 112,990 fully paid up equity shares of Re. 1/- each of the Company, to certain employees on exercise of stock options granted to them pursuant to JBCPL Employee Stock Option Scheme, 2021. An amount of Rs. 5,16,30,125 has been realised on exercise of 112,990 stock options.
Consequently, the issued, subscribed and paid up capital has increased from 15,58,60,544 equity shares of Re. 1 each to 15,59,73,534 equity shares of Re. 1 each.
Board of J B Chemicals & Pharmaceuticals recommends final dividend
15 - May - 2025 12:00 | 33 days ago
J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 7 per equity Share (i.e. 700%) , subject to the approval of the shareholders.
J B Chemicals & Pharmaceuticals consolidated net profit rises 15.48% in the March 2025 quarter
15 - May - 2025 12:00 | 33 days ago
Net profit of J B Chemicals & Pharmaceuticals rose 15.48% to Rs 145.69 crore in the quarter ended March 2025 as against Rs 126.16 crore during the previous quarter ended March 2024. Sales rose 10.18% to Rs 949.48 crore in the quarter ended March 2025 as against Rs 861.73 crore during the previous quarter ended March 2024.
For the full year,net profit rose 19.35% to Rs 659.58 crore in the year ended March 2025 as against Rs 552.63 crore during the previous year ended March 2024. Sales rose 12.45% to Rs 3917.99 crore in the year ended March 2025 as against Rs 3484.18 crore during the previous year ended March 2024.
